Related Experiment Videos
Our human genome--how can it serve us well?
Bulletin of the World Health Organization
|December 4, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Proton Bunch Self-Modulation in Plasma with Density Gradient.
Physical review letters·2021
Proton-driven plasma wakefield acceleration in AWAKE.
Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2019
Experimental Observation of Plasma Wakefield Growth Driven by the Seeded Self-Modulation of a Proton Bunch.
Physical review letters·2019
Expedited research and approval of medicines for drug-resistant bacterial infections in children.
Bulletin of the World Health Organization·2026
A model for the epidemiological impact of tuberculosis policy options.
Bulletin of the World Health Organization·2026
Telephone versus in-person administration of the Early Childhood Development Index 2030: a crossover study, Brazil, Canada, India and Malawi.
Bulletin of the World Health Organization·2026
Digital epidemiology investments, Saudi Arabia.
Bulletin of the World Health Organization·2026
Identification of unvaccinated children, Madagascar.
Bulletin of the World Health Organization·2026
Third-party governance and artificial intelligence for diabetes management in primary health care, China.
Bulletin of the World Health Organization·2026
Complete genome sequence of Streptococcus vaginalis strain UMB8616 isolated from the bladder of a female with urge urinary incontinence.
Microbiology resource announcements·2026
Complete genome sequence of Sphingobacterium kitahiroshimense strain Ss8-5, isolated from a sclerotium of Sclerotinia sclerotiorum.
Microbiology resource announcements·2026
A population-specific genomic reference panel for Taiwan: NHRI-RP-1.
Journal of biomedical science·2026
A genome-wide assessment of the population structure of thirteen admixed and pure Australian beef cattle breeds.
Journal of animal science·2026
ApoC-III Antisense Oligonucleotide Therapy Used in Glycogen Storage Disease Type 1a.
JACC. Case reports·2026